Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 19, 2021

SELL
$46.59 - $83.68 $171,078 - $307,272
-3,672 Closed
0 $0
Q4 2020

Mar 05, 2021

BUY
$18.83 - $63.53 $790 - $2,668
42 Added 1.16%
3,672 $200,000
Q3 2020

Nov 17, 2020

BUY
$17.47 - $24.93 $63,416 - $90,495
3,630 New
3,630 $72,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $837M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Bnc Wealth Management, LLC Portfolio

Follow Bnc Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnc Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bnc Wealth Management, LLC with notifications on news.